Towarzystwo Funduszy Inwestycyjnych PZU SA’s Regeneron Pharmaceuticals REGN Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$209K	Buy	335 +30	+10%	+$20.4K	0.06%	195
2026 Q1	$236K	Sell	305 -71	-19%	-$54.4K	0.08%	165
2025 Q4	$290K	Buy	376 +22	+6%	+$14.9K	0.07%	151
2025 Q3	$199K	Sell	354 -330	-48%	-$187K	0.05%	179
2025 Q2	$359K	Buy	684 +184	+37%	+$103K	0.1%	107
2025 Q1	$317K	Buy	500 +95	+23%	+$65.3K	0.11%	96
2024 Q4	$288K	Sell	405 -35	-8%	-$29.4K	0.1%	89
2024 Q3	$463K	Buy	440 +50	+13%	+$55.6K	0.17%	58
2024 Q2	$410K	Sell	390 -10	-3%	-$9.69K	0.15%	60
2024 Q1	$385K	Buy	400 +52	+15%	+$49.4K	0.16%	63
2023 Q4	$306K	Buy	+348	New	+$287K	0.14%	67
2021 Q3	$36.3K	Hold	60	–	–	0.04%	162
2021 Q2	$33.5K	Hold	60	–	–	0.04%	189
2021 Q1	$28.4K	Hold	60	–	–	0.04%	190
2020 Q4	$29K	Buy	+60	New	+$32.4K	0.03%	160

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's REGN Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Regeneron Pharmaceuticals (REGN) stake by 9.8% in Q2 2026, buying an estimated $20.4K and bringing the position to 335 shares worth $209K. The position accounts for 0.06% of the portfolio, ranked #195.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in REGN in Q4 2020 and has held it in 15 quarters since. The position peaked at $463K in Q3 2024. 955 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Towarzystwo Funduszy Inwestycyjnych PZU SA held 335 shares of Regeneron Pharmaceuticals worth $209K as of Q2 2026.
Towarzystwo Funduszy Inwestycyjnych PZU SA bought 30 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $20.4K.
Regeneron Pharmaceuticals made up 0.06% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #195 holding.
Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Regeneron Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
Towarzystwo Funduszy Inwestycyjnych PZU SA's Regeneron Pharmaceuticals position peaked at $463K in Q3 2024.
955 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.